Skip to content
Screener

Globus Medical GMED Operating Cash Flow

Operating Cash Flow at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$8.62B+122%
Stryker logo
StrykerSYK
$1.26B+13.5%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$6.22M-153%
Boston Scientific logo
Boston ScientificBSX
$348M-35.7%
IAR
Integra LifeSciencesIART
$22.8M+156%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$447.8M+18.4%

Other financials

Income statement

See full
Revenue$789.6M+5.9%
Gross profit$548.2M+10.4%
Operating income$182.4M+140%
Net income$151.6M-25.3%
EPS (diluted)$1.10-26.2%

Balance sheet

See full
Cash & equivalents$507.7M+121%
Total debt$112.3M-7.6%
Total equity$4.8B+11.0%
Total assets$5.5B+10.6%

Cash flow

See full
CapEx$33.2M-28.8%
Free cash flow$176.6M+464%

Valuation

See full
Market cap$10.93B+52.9%
Enterprise value$10.54B+49.6%
P/E20.4×+0.4×
P/S3.5×+0.8×

Profitability

See full
Gross margin68.5%+5.8pp
Operating margin20.3%+9.6pp
Net margin17%+3.4pp
FCF margin24%+3.9pp

Returns & leverage

See full
Return on equity11.8%+3.2pp
Debt / equity0.0×
Current ratio4.6×+0.5×

Where this comes from

Reported directly by Globus Medical in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: Globus Medical’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054450
(In thousands)Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Accounts payable5,389(4,085)
Accrued expenses and other liabilities(35,738)(13,841)
Income taxes payable/receivable19,387(38,626)
Net cash provided by/(used in) operating activities412,105255,165
Cash flows from investing activities:
Purchases of marketable securities(254,013)(1,750)
Sales and maturities of marketable securities21,483174,238
Purchases of property and equipment(72,783)(82,665)

Item 1. Financial Statements

FAQ

What is Globus Medical's operating cash flow?
Globus Medical (GMED) reported operating cash flow of $209.74M in Q2 2026.
How has Globus Medical's operating cash flow changed year-over-year?
Globus Medical's operating cash flow increased by 169.4% year-over-year, from $77.87M to $209.74M.
What is the long-term trend for Globus Medical's operating cash flow?
Over 4 years (2021 to 2025), Globus Medical's operating cash flow has grown at a 28.5% compound annual growth rate (CAGR), from $276.27M to $753.45M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about Globus Medical's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude